Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel
Links shared publicly online about this topic.
- 670total visits
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel
Experimental drug Contrave(R) (naltrexone SR/bupropion SR) for the treatment of obesity has been recommended for approval by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee. The Co
View full resource at medicalnewstoday.com
Tags: Metabolic, Obesity, Obesity Medication, Drug, FDA, Contrave
Most Recently Shared on December 8, 2010 at 9:27 pm By:
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel: Experimental drug Contrave(R) (naltrexone SR/bu... http://mnt.to/f/3NNj
Also Shared By:
Advertisement
medical_tweets
@medical_tweets
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel Experimental drug Contrave(R) (naltrexone SR/bupropion .. http://dld.bz/9Ufx
1 year ago...